EZH2 regulates expression of FOXC1 by mediating H3K27me3 in breast cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EZH2 regulates expression of FOXC1 by mediating H3K27me3 in breast cancers

Published:2020-10-14 Issue:7 Volume:42 Page:1171-1179
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Zheng Xiang-jin,Li Wan,Yi Jie,Liu Jin-yi,Ren Li-wen,Zhu Xiao-ming,Liu Shi-wei,Wang Jin-hua,Du Guan-hua

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-020-00543-x.pdf

Reference38 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.

2. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52–62.

3. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938–48.

4. Wang J, Li W, Zhao Y, Kang FuW, Zheng X, et al. Members of FOX family could be drug targets of cancers. Pharmacol Ther. 2018;181:183–96.

5. Wang J, Li W, Zheng X, Pang X, Du G. Research progress on the forkhead box C1. Oncotarget. 2018;9:12471–8.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-target EZH2 inhibitor: latest advances in medicinal chemistry;Future Medicinal Chemistry;2024-07-31

2. Research progress on the regulatory mechanisms of FOXC1 expression in cancers and its role in drug resistance;Gene;2024-03

3. Dual target PARP1/EZH2 inhibitors inducing excessive autophagy and producing synthetic lethality for triple-negative breast cancer therapy;European Journal of Medicinal Chemistry;2024-02

4. Feedback Loop of EZH2/miR-101 Regulates Autophagy and Apoptosis by Targeting mTOR in Glioblastoma Cells;J BIOL REG HOMEOS AG;2024

5. Comprehensive Analysis of the Role of Forkhead Box J3 (FOXJ3) in Human Cancers;Wuhan University Journal of Natural Sciences;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3